“In a stunning achievement, Maven, a groundbreaking healthcare startup, soared to unicorn status within the femtech sector in 2022, amassing a colossal $250 million in funding from a constellation of illustrious investors, including the incomparable Oprah Winfrey, the esteemed Natalie Portman, and the remarkable Reese Witherspoon. Maven’s revolutionary offerings encompass an extensive array of virtual clinic services dedicated to women and families, spanning the domains of fertility, maternity and newborn care, pediatrics, and menopause. Furthermore, the company extends its support to encompass financial assistance and mental health provisions, fortifying its commitment to holistic care. Its astonishing reach encompasses a staggering 15 million members enlisted across an expansive tapestry of 175 countries.
Maven stands resolute as an end-to-end solution, ensuring uninterrupted continuity of care, irrespective of the unique journeys traversed by its diverse clientele,” asserts Kate Ryder, the luminary CEO. Ryder further elucidates, providing a poignant example, “Presently, we are fervently aiding a resilient woman in London who initially enrolled in our fertility program. Tragically, she encountered a heartbreaking pregnancy loss after a mere eight weeks. Undeterred, she has returned to our fertility program, and we are wholeheartedly supporting her in navigating the intricate process of cross-border egg donation, bridging the gap between Spain and the UK.”
Birthed into existence in 2014 by Ryder herself, then an astute associate at the venerable venture capital firm Index Ventures in London, Maven was an innovative response to the conundrum that confounded the digital health landscape of the time – patient engagement. Ryder nostalgically recollects, “At that juncture, digital health was an area of burgeoning interest, and the prevailing challenge that captivated everyone’s attention was patient engagement. Astonishingly, despite women constituting a significant proportion of consumers, their health was woefully overlooked, and this void beckoned me to embark on this transformative venture.”
Regrettably, even in the present day, the landscape remains bleak, as stark data unequivocally demonstrates the gross neglect that continues to plague women’s healthcare. The distressing reality unveils that one in every five women suffers from postpartum depression, devoid of the requisite mental health support, while an astounding four out of five women grappling with menopause are unjustly deprived of the essential care they deserve, as revealed by the esteemed UK Department of Health and Social Care.
This disheartening gender health gap is precisely the chasm that Ryder ardently endeavors to bridge. Maven’s resounding impact is epitomized by the staggering figures: a staggering 6,000 appointments are seamlessly facilitated each week, with members enjoying the privilege of securing appointments in under an hour, with the added bonus of being matched with their preferred experts. Maven’s unwavering dedication to evidence-based practices and substantiating its efficacy culminated in the publication of peer-reviewed studies in the esteemed medical journal, The Lancet, last year. These groundbreaking studies irrefutably proved the remarkable effectiveness of Maven’s pioneering model. For instance, patients who consulted with a virtual ob-gyn witnessed a remarkable 4.2-fold reduction in emergency room visits, while first-time mothers who underwent Maven’s exceptional maternity care programs experienced a staggering 27 percent decrease in cesarean section rates. Ryder confidently asserts, “We scrupulously scrutinize objective claims analyses to gauge the impact of our virtual model on outcomes. The results we unearth are truly magical, a testament to the unparalleled synergy inherent in our comprehensive approach.”